Loading clinical trials...
Loading clinical trials...
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device for Solid Pancreatic Lesions: a Prospective Multi-center, Randomized, and Controlled Trial
Conditions
Interventions
Using 22G FNB, the first pass is SP
Using 22G FNB, the first pass is MWST
+2 more
Locations
1
China
Bin Cheng
Wuhan, Hubei, China
Start Date
March 1, 2019
Primary Completion Date
June 1, 2020
Completion Date
August 1, 2020
Last Updated
January 17, 2019
Lead Sponsor
Huazhong University of Science and Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions